nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—RXRA—thyroid cancer	0.562	1	CbGaD
Tretinoin—CYP3A7—Sorafenib—thyroid cancer	0.0214	0.155	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0214	0.155	CbGbCtD
Tretinoin—CYP2B6—Sorafenib—thyroid cancer	0.0204	0.147	CbGbCtD
Tretinoin—CYP3A5—Sorafenib—thyroid cancer	0.0161	0.116	CbGbCtD
Tretinoin—CYP2C8—Sorafenib—thyroid cancer	0.0155	0.112	CbGbCtD
Tretinoin—CYP2B6—Doxorubicin—thyroid cancer	0.0124	0.0894	CbGbCtD
Tretinoin—CYP2C9—Sorafenib—thyroid cancer	0.0108	0.0779	CbGbCtD
Tretinoin—CYP3A4—Vandetanib—thyroid cancer	0.0104	0.0751	CbGbCtD
Tretinoin—CYP3A4—Sorafenib—thyroid cancer	0.00627	0.0453	CbGbCtD
Tretinoin—CYP3A4—Doxorubicin—thyroid cancer	0.00381	0.0275	CbGbCtD
Tretinoin—RARRES1—saliva-secreting gland—thyroid cancer	0.00301	0.0649	CbGeAlD
Tretinoin—CRABP1—neck—thyroid cancer	0.00286	0.0616	CbGeAlD
Tretinoin—RARRES1—trachea—thyroid cancer	0.00232	0.05	CbGeAlD
Tretinoin—Isotretinoin—RXRA—thyroid cancer	0.00226	0.375	CrCbGaD
Tretinoin—RXRG—neck—thyroid cancer	0.00226	0.0487	CbGeAlD
Tretinoin—ALDH1A1—neck—thyroid cancer	0.00215	0.0464	CbGeAlD
Tretinoin—Acitretin—RXRA—thyroid cancer	0.00192	0.319	CrCbGaD
Tretinoin—Alitretinoin—RXRA—thyroid cancer	0.00184	0.306	CrCbGaD
Tretinoin—RARRES1—thyroid gland—thyroid cancer	0.00184	0.0396	CbGeAlD
Tretinoin—CRABP1—trachea—thyroid cancer	0.00172	0.037	CbGeAlD
Tretinoin—ALDH1A1—saliva-secreting gland—thyroid cancer	0.00168	0.0362	CbGeAlD
Tretinoin—CRABP2—trachea—thyroid cancer	0.00155	0.0335	CbGeAlD
Tretinoin—ALDH1A2—thyroid gland—thyroid cancer	0.00141	0.0304	CbGeAlD
Tretinoin—ALDH1A1—Idarubicin—Epirubicin—thyroid cancer	0.00136	0.519	CbGdCrCtD
Tretinoin—CRABP1—thyroid gland—thyroid cancer	0.00136	0.0293	CbGeAlD
Tretinoin—ALDH1A1—trachea—thyroid cancer	0.0013	0.0279	CbGeAlD
Tretinoin—ALDH1A1—Idarubicin—Doxorubicin—thyroid cancer	0.00126	0.481	CbGdCrCtD
Tretinoin—ALDH1A2—head—thyroid cancer	0.00125	0.0269	CbGeAlD
Tretinoin—CRABP2—thyroid gland—thyroid cancer	0.00123	0.0265	CbGeAlD
Tretinoin—CRABP1—head—thyroid cancer	0.00121	0.026	CbGeAlD
Tretinoin—RARRES1—lymph node—thyroid cancer	0.00114	0.0246	CbGeAlD
Tretinoin—RARB—thyroid gland—thyroid cancer	0.0011	0.0237	CbGeAlD
Tretinoin—CRABP2—head—thyroid cancer	0.00109	0.0235	CbGeAlD
Tretinoin—RXRA—head—thyroid cancer	0.00109	0.0234	CbGeAlD
Tretinoin—RXRG—thyroid gland—thyroid cancer	0.00107	0.0232	CbGeAlD
Tretinoin—ALDH1A1—thyroid gland—thyroid cancer	0.00102	0.0221	CbGeAlD
Tretinoin—RXRB—thyroid gland—thyroid cancer	0.00101	0.0218	CbGeAlD
Tretinoin—RARB—head—thyroid cancer	0.000976	0.021	CbGeAlD
Tretinoin—RXRG—head—thyroid cancer	0.000954	0.0206	CbGeAlD
Tretinoin—ALDH1A1—head—thyroid cancer	0.000909	0.0196	CbGeAlD
Tretinoin—RARG—thyroid gland—thyroid cancer	0.000897	0.0193	CbGeAlD
Tretinoin—RXRB—head—thyroid cancer	0.000897	0.0193	CbGeAlD
Tretinoin—ALDH1A2—lymph node—thyroid cancer	0.000876	0.0189	CbGeAlD
Tretinoin—RARA—thyroid gland—thyroid cancer	0.000844	0.0182	CbGeAlD
Tretinoin—RARG—head—thyroid cancer	0.000796	0.0172	CbGeAlD
Tretinoin—RARA—head—thyroid cancer	0.000748	0.0161	CbGeAlD
Tretinoin—RARB—lymph node—thyroid cancer	0.000683	0.0147	CbGeAlD
Tretinoin—ALDH1A1—lymph node—thyroid cancer	0.000637	0.0137	CbGeAlD
Tretinoin—RARG—lymph node—thyroid cancer	0.000557	0.012	CbGeAlD
Tretinoin—RARA—lymph node—thyroid cancer	0.000524	0.0113	CbGeAlD
Tretinoin—CYP1A1—trachea—thyroid cancer	0.00039	0.0084	CbGeAlD
Tretinoin—CYP1A1—thyroid gland—thyroid cancer	0.000308	0.00665	CbGeAlD
Tretinoin—CYP1A1—head—thyroid cancer	0.000274	0.0059	CbGeAlD
Tretinoin—CYP2B6—head—thyroid cancer	0.000266	0.00573	CbGeAlD
Tretinoin—CYP1A1—lymph node—thyroid cancer	0.000192	0.00413	CbGeAlD
Tretinoin—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000105	0.000782	CcSEcCtD
Tretinoin—Hypersensitivity—Sorafenib—thyroid cancer	0.000105	0.000782	CcSEcCtD
Tretinoin—Renal impairment—Doxorubicin—thyroid cancer	0.000105	0.000775	CcSEcCtD
Tretinoin—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000104	0.000772	CcSEcCtD
Tretinoin—Face oedema—Epirubicin—thyroid cancer	0.000104	0.00077	CcSEcCtD
Tretinoin—Asthenia—Sorafenib—thyroid cancer	0.000103	0.000761	CcSEcCtD
Tretinoin—Cardiac arrest—Epirubicin—thyroid cancer	0.000102	0.000758	CcSEcCtD
Tretinoin—Cardiac failure—Doxorubicin—thyroid cancer	0.000102	0.000756	CcSEcCtD
Tretinoin—Mood swings—Epirubicin—thyroid cancer	0.000102	0.000756	CcSEcCtD
Tretinoin—Lethargy—Doxorubicin—thyroid cancer	0.000102	0.000753	CcSEcCtD
Tretinoin—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000102	0.000753	CcSEcCtD
Tretinoin—Pruritus—Sorafenib—thyroid cancer	0.000101	0.00075	CcSEcCtD
Tretinoin—Blood creatinine increased—Epirubicin—thyroid cancer	0.000101	0.000747	CcSEcCtD
Tretinoin—Dehydration—Epirubicin—thyroid cancer	0.0001	0.000742	CcSEcCtD
Tretinoin—Osteoarthritis—Doxorubicin—thyroid cancer	9.95e-05	0.000738	CcSEcCtD
Tretinoin—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	9.95e-05	0.000738	CcSEcCtD
Tretinoin—Pain in extremity—Doxorubicin—thyroid cancer	9.95e-05	0.000738	CcSEcCtD
Tretinoin—Dry skin—Epirubicin—thyroid cancer	9.86e-05	0.000731	CcSEcCtD
Tretinoin—Affect lability—Doxorubicin—thyroid cancer	9.8e-05	0.000726	CcSEcCtD
Tretinoin—Diarrhoea—Sorafenib—thyroid cancer	9.79e-05	0.000726	CcSEcCtD
Tretinoin—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	9.69e-05	0.000718	CcSEcCtD
Tretinoin—Nasopharyngitis—Epirubicin—thyroid cancer	9.62e-05	0.000713	CcSEcCtD
Tretinoin—Face oedema—Doxorubicin—thyroid cancer	9.61e-05	0.000712	CcSEcCtD
Tretinoin—Gastritis—Epirubicin—thyroid cancer	9.52e-05	0.000706	CcSEcCtD
Tretinoin—Cardiac arrest—Doxorubicin—thyroid cancer	9.46e-05	0.000702	CcSEcCtD
Tretinoin—Dizziness—Sorafenib—thyroid cancer	9.46e-05	0.000701	CcSEcCtD
Tretinoin—Mood swings—Doxorubicin—thyroid cancer	9.43e-05	0.000699	CcSEcCtD
Tretinoin—Abdominal distension—Epirubicin—thyroid cancer	9.36e-05	0.000694	CcSEcCtD
Tretinoin—Blood creatinine increased—Doxorubicin—thyroid cancer	9.32e-05	0.000691	CcSEcCtD
Tretinoin—Dysphagia—Epirubicin—thyroid cancer	9.3e-05	0.000689	CcSEcCtD
Tretinoin—Asthma—Epirubicin—thyroid cancer	9.3e-05	0.000689	CcSEcCtD
Tretinoin—Dehydration—Doxorubicin—thyroid cancer	9.25e-05	0.000686	CcSEcCtD
Tretinoin—Dry skin—Doxorubicin—thyroid cancer	9.12e-05	0.000676	CcSEcCtD
Tretinoin—Pancreatitis—Epirubicin—thyroid cancer	9.11e-05	0.000676	CcSEcCtD
Tretinoin—Vomiting—Sorafenib—thyroid cancer	9.09e-05	0.000674	CcSEcCtD
Tretinoin—Rash—Sorafenib—thyroid cancer	9.02e-05	0.000669	CcSEcCtD
Tretinoin—Dermatitis—Sorafenib—thyroid cancer	9.01e-05	0.000668	CcSEcCtD
Tretinoin—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	8.96e-05	0.000665	CcSEcCtD
Tretinoin—Headache—Sorafenib—thyroid cancer	8.96e-05	0.000665	CcSEcCtD
Tretinoin—Nasopharyngitis—Doxorubicin—thyroid cancer	8.9e-05	0.00066	CcSEcCtD
Tretinoin—Gastritis—Doxorubicin—thyroid cancer	8.81e-05	0.000653	CcSEcCtD
Tretinoin—Dysuria—Epirubicin—thyroid cancer	8.69e-05	0.000645	CcSEcCtD
Tretinoin—Neutropenia—Epirubicin—thyroid cancer	8.69e-05	0.000645	CcSEcCtD
Tretinoin—Abdominal distension—Doxorubicin—thyroid cancer	8.66e-05	0.000642	CcSEcCtD
Tretinoin—Upper respiratory tract infection—Epirubicin—thyroid cancer	8.64e-05	0.000641	CcSEcCtD
Tretinoin—Asthma—Doxorubicin—thyroid cancer	8.6e-05	0.000638	CcSEcCtD
Tretinoin—Dysphagia—Doxorubicin—thyroid cancer	8.6e-05	0.000638	CcSEcCtD
Tretinoin—Pollakiuria—Epirubicin—thyroid cancer	8.59e-05	0.000637	CcSEcCtD
Tretinoin—Nausea—Sorafenib—thyroid cancer	8.5e-05	0.00063	CcSEcCtD
Tretinoin—Photosensitivity reaction—Epirubicin—thyroid cancer	8.49e-05	0.000629	CcSEcCtD
Tretinoin—Weight increased—Epirubicin—thyroid cancer	8.46e-05	0.000627	CcSEcCtD
Tretinoin—Pancreatitis—Doxorubicin—thyroid cancer	8.43e-05	0.000625	CcSEcCtD
Tretinoin—Weight decreased—Epirubicin—thyroid cancer	8.41e-05	0.000624	CcSEcCtD
Tretinoin—Pneumonia—Epirubicin—thyroid cancer	8.34e-05	0.000618	CcSEcCtD
Tretinoin—Infestation—Epirubicin—thyroid cancer	8.29e-05	0.000615	CcSEcCtD
Tretinoin—Infestation NOS—Epirubicin—thyroid cancer	8.29e-05	0.000615	CcSEcCtD
Tretinoin—Drowsiness—Epirubicin—thyroid cancer	8.29e-05	0.000615	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	8.22e-05	0.000609	CcSEcCtD
Tretinoin—Renal failure—Epirubicin—thyroid cancer	8.15e-05	0.000604	CcSEcCtD
Tretinoin—Neuropathy peripheral—Epirubicin—thyroid cancer	8.12e-05	0.000603	CcSEcCtD
Tretinoin—Stomatitis—Epirubicin—thyroid cancer	8.08e-05	0.000599	CcSEcCtD
Tretinoin—Urinary tract infection—Epirubicin—thyroid cancer	8.06e-05	0.000597	CcSEcCtD
Tretinoin—Conjunctivitis—Epirubicin—thyroid cancer	8.06e-05	0.000597	CcSEcCtD
Tretinoin—Dysuria—Doxorubicin—thyroid cancer	8.04e-05	0.000596	CcSEcCtD
Tretinoin—Neutropenia—Doxorubicin—thyroid cancer	8.04e-05	0.000596	CcSEcCtD
Tretinoin—Upper respiratory tract infection—Doxorubicin—thyroid cancer	7.99e-05	0.000593	CcSEcCtD
Tretinoin—Sweating—Epirubicin—thyroid cancer	7.95e-05	0.000589	CcSEcCtD
Tretinoin—Pollakiuria—Doxorubicin—thyroid cancer	7.95e-05	0.000589	CcSEcCtD
Tretinoin—Haematuria—Epirubicin—thyroid cancer	7.9e-05	0.000586	CcSEcCtD
Tretinoin—Photosensitivity reaction—Doxorubicin—thyroid cancer	7.85e-05	0.000582	CcSEcCtD
Tretinoin—Weight increased—Doxorubicin—thyroid cancer	7.83e-05	0.000581	CcSEcCtD
Tretinoin—Epistaxis—Epirubicin—thyroid cancer	7.82e-05	0.00058	CcSEcCtD
Tretinoin—Weight decreased—Doxorubicin—thyroid cancer	7.78e-05	0.000577	CcSEcCtD
Tretinoin—Sinusitis—Epirubicin—thyroid cancer	7.78e-05	0.000577	CcSEcCtD
Tretinoin—Agranulocytosis—Epirubicin—thyroid cancer	7.73e-05	0.000574	CcSEcCtD
Tretinoin—Pneumonia—Doxorubicin—thyroid cancer	7.71e-05	0.000572	CcSEcCtD
Tretinoin—Infestation—Doxorubicin—thyroid cancer	7.67e-05	0.000569	CcSEcCtD
Tretinoin—Infestation NOS—Doxorubicin—thyroid cancer	7.67e-05	0.000569	CcSEcCtD
Tretinoin—Drowsiness—Doxorubicin—thyroid cancer	7.67e-05	0.000569	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	7.6e-05	0.000564	CcSEcCtD
Tretinoin—Renal failure—Doxorubicin—thyroid cancer	7.54e-05	0.000559	CcSEcCtD
Tretinoin—Neuropathy peripheral—Doxorubicin—thyroid cancer	7.52e-05	0.000557	CcSEcCtD
Tretinoin—Haemoglobin—Epirubicin—thyroid cancer	7.48e-05	0.000555	CcSEcCtD
Tretinoin—Stomatitis—Doxorubicin—thyroid cancer	7.48e-05	0.000554	CcSEcCtD
Tretinoin—Conjunctivitis—Doxorubicin—thyroid cancer	7.45e-05	0.000553	CcSEcCtD
Tretinoin—Urinary tract infection—Doxorubicin—thyroid cancer	7.45e-05	0.000553	CcSEcCtD
Tretinoin—Haemorrhage—Epirubicin—thyroid cancer	7.44e-05	0.000552	CcSEcCtD
Tretinoin—Hepatitis—Epirubicin—thyroid cancer	7.44e-05	0.000552	CcSEcCtD
Tretinoin—Hypoaesthesia—Epirubicin—thyroid cancer	7.4e-05	0.000549	CcSEcCtD
Tretinoin—Pharyngitis—Epirubicin—thyroid cancer	7.38e-05	0.000548	CcSEcCtD
Tretinoin—Sweating—Doxorubicin—thyroid cancer	7.35e-05	0.000545	CcSEcCtD
Tretinoin—Urinary tract disorder—Epirubicin—thyroid cancer	7.35e-05	0.000545	CcSEcCtD
Tretinoin—Oedema peripheral—Epirubicin—thyroid cancer	7.33e-05	0.000544	CcSEcCtD
Tretinoin—Haematuria—Doxorubicin—thyroid cancer	7.31e-05	0.000542	CcSEcCtD
Tretinoin—Urethral disorder—Epirubicin—thyroid cancer	7.29e-05	0.000541	CcSEcCtD
Tretinoin—Epistaxis—Doxorubicin—thyroid cancer	7.23e-05	0.000536	CcSEcCtD
Tretinoin—Sinusitis—Doxorubicin—thyroid cancer	7.2e-05	0.000534	CcSEcCtD
Tretinoin—Visual impairment—Epirubicin—thyroid cancer	7.17e-05	0.000532	CcSEcCtD
Tretinoin—Agranulocytosis—Doxorubicin—thyroid cancer	7.16e-05	0.000531	CcSEcCtD
Tretinoin—Erythema multiforme—Epirubicin—thyroid cancer	7.04e-05	0.000522	CcSEcCtD
Tretinoin—Eye disorder—Epirubicin—thyroid cancer	6.95e-05	0.000516	CcSEcCtD
Tretinoin—Tinnitus—Epirubicin—thyroid cancer	6.94e-05	0.000514	CcSEcCtD
Tretinoin—Haemoglobin—Doxorubicin—thyroid cancer	6.92e-05	0.000513	CcSEcCtD
Tretinoin—Flushing—Epirubicin—thyroid cancer	6.91e-05	0.000512	CcSEcCtD
Tretinoin—Hepatitis—Doxorubicin—thyroid cancer	6.88e-05	0.000511	CcSEcCtD
Tretinoin—Haemorrhage—Doxorubicin—thyroid cancer	6.88e-05	0.000511	CcSEcCtD
Tretinoin—Hypoaesthesia—Doxorubicin—thyroid cancer	6.85e-05	0.000508	CcSEcCtD
Tretinoin—Pharyngitis—Doxorubicin—thyroid cancer	6.83e-05	0.000507	CcSEcCtD
Tretinoin—Urinary tract disorder—Doxorubicin—thyroid cancer	6.8e-05	0.000504	CcSEcCtD
Tretinoin—Oedema peripheral—Doxorubicin—thyroid cancer	6.78e-05	0.000503	CcSEcCtD
Tretinoin—Angiopathy—Epirubicin—thyroid cancer	6.75e-05	0.000501	CcSEcCtD
Tretinoin—Urethral disorder—Doxorubicin—thyroid cancer	6.75e-05	0.0005	CcSEcCtD
Tretinoin—Chills—Epirubicin—thyroid cancer	6.68e-05	0.000495	CcSEcCtD
Tretinoin—Arrhythmia—Epirubicin—thyroid cancer	6.65e-05	0.000493	CcSEcCtD
Tretinoin—Visual impairment—Doxorubicin—thyroid cancer	6.63e-05	0.000492	CcSEcCtD
Tretinoin—Alopecia—Epirubicin—thyroid cancer	6.57e-05	0.000488	CcSEcCtD
Tretinoin—Mental disorder—Epirubicin—thyroid cancer	6.52e-05	0.000483	CcSEcCtD
Tretinoin—Erythema multiforme—Doxorubicin—thyroid cancer	6.51e-05	0.000483	CcSEcCtD
Tretinoin—Malnutrition—Epirubicin—thyroid cancer	6.48e-05	0.00048	CcSEcCtD
Tretinoin—Erythema—Epirubicin—thyroid cancer	6.48e-05	0.00048	CcSEcCtD
Tretinoin—Eye disorder—Doxorubicin—thyroid cancer	6.43e-05	0.000477	CcSEcCtD
Tretinoin—Tinnitus—Doxorubicin—thyroid cancer	6.42e-05	0.000476	CcSEcCtD
Tretinoin—Flushing—Doxorubicin—thyroid cancer	6.39e-05	0.000474	CcSEcCtD
Tretinoin—Flatulence—Epirubicin—thyroid cancer	6.38e-05	0.000473	CcSEcCtD
Tretinoin—Tension—Epirubicin—thyroid cancer	6.36e-05	0.000471	CcSEcCtD
Tretinoin—Nervousness—Epirubicin—thyroid cancer	6.29e-05	0.000467	CcSEcCtD
Tretinoin—Back pain—Epirubicin—thyroid cancer	6.27e-05	0.000465	CcSEcCtD
Tretinoin—Angiopathy—Doxorubicin—thyroid cancer	6.25e-05	0.000463	CcSEcCtD
Tretinoin—Chills—Doxorubicin—thyroid cancer	6.18e-05	0.000458	CcSEcCtD
Tretinoin—Arrhythmia—Doxorubicin—thyroid cancer	6.15e-05	0.000456	CcSEcCtD
Tretinoin—Vision blurred—Epirubicin—thyroid cancer	6.1e-05	0.000453	CcSEcCtD
Tretinoin—Alopecia—Doxorubicin—thyroid cancer	6.08e-05	0.000451	CcSEcCtD
Tretinoin—Mental disorder—Doxorubicin—thyroid cancer	6.03e-05	0.000447	CcSEcCtD
Tretinoin—Ill-defined disorder—Epirubicin—thyroid cancer	6.01e-05	0.000446	CcSEcCtD
Tretinoin—Malnutrition—Doxorubicin—thyroid cancer	5.99e-05	0.000444	CcSEcCtD
Tretinoin—Erythema—Doxorubicin—thyroid cancer	5.99e-05	0.000444	CcSEcCtD
Tretinoin—Anaemia—Epirubicin—thyroid cancer	5.99e-05	0.000444	CcSEcCtD
Tretinoin—Agitation—Epirubicin—thyroid cancer	5.95e-05	0.000441	CcSEcCtD
Tretinoin—Flatulence—Doxorubicin—thyroid cancer	5.91e-05	0.000438	CcSEcCtD
Tretinoin—Tension—Doxorubicin—thyroid cancer	5.88e-05	0.000436	CcSEcCtD
Tretinoin—Malaise—Epirubicin—thyroid cancer	5.84e-05	0.000433	CcSEcCtD
Tretinoin—Nervousness—Doxorubicin—thyroid cancer	5.82e-05	0.000432	CcSEcCtD
Tretinoin—Syncope—Epirubicin—thyroid cancer	5.81e-05	0.000431	CcSEcCtD
Tretinoin—Back pain—Doxorubicin—thyroid cancer	5.8e-05	0.00043	CcSEcCtD
Tretinoin—Palpitations—Epirubicin—thyroid cancer	5.72e-05	0.000424	CcSEcCtD
Tretinoin—Loss of consciousness—Epirubicin—thyroid cancer	5.69e-05	0.000422	CcSEcCtD
Tretinoin—Cough—Epirubicin—thyroid cancer	5.65e-05	0.000419	CcSEcCtD
Tretinoin—Vision blurred—Doxorubicin—thyroid cancer	5.65e-05	0.000419	CcSEcCtD
Tretinoin—Convulsion—Epirubicin—thyroid cancer	5.61e-05	0.000416	CcSEcCtD
Tretinoin—Hypertension—Epirubicin—thyroid cancer	5.59e-05	0.000415	CcSEcCtD
Tretinoin—Ill-defined disorder—Doxorubicin—thyroid cancer	5.56e-05	0.000412	CcSEcCtD
Tretinoin—Anaemia—Doxorubicin—thyroid cancer	5.54e-05	0.000411	CcSEcCtD
Tretinoin—Myalgia—Epirubicin—thyroid cancer	5.51e-05	0.000409	CcSEcCtD
Tretinoin—Arthralgia—Epirubicin—thyroid cancer	5.51e-05	0.000409	CcSEcCtD
Tretinoin—Chest pain—Epirubicin—thyroid cancer	5.51e-05	0.000409	CcSEcCtD
Tretinoin—Agitation—Doxorubicin—thyroid cancer	5.51e-05	0.000408	CcSEcCtD
Tretinoin—Anxiety—Epirubicin—thyroid cancer	5.5e-05	0.000408	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	5.48e-05	0.000406	CcSEcCtD
Tretinoin—Discomfort—Epirubicin—thyroid cancer	5.45e-05	0.000404	CcSEcCtD
Tretinoin—Malaise—Doxorubicin—thyroid cancer	5.4e-05	0.000401	CcSEcCtD
Tretinoin—Dry mouth—Epirubicin—thyroid cancer	5.39e-05	0.0004	CcSEcCtD
Tretinoin—Syncope—Doxorubicin—thyroid cancer	5.37e-05	0.000399	CcSEcCtD
Tretinoin—Confusional state—Epirubicin—thyroid cancer	5.33e-05	0.000395	CcSEcCtD
Tretinoin—Palpitations—Doxorubicin—thyroid cancer	5.3e-05	0.000393	CcSEcCtD
Tretinoin—Anaphylactic shock—Epirubicin—thyroid cancer	5.29e-05	0.000392	CcSEcCtD
Tretinoin—Oedema—Epirubicin—thyroid cancer	5.29e-05	0.000392	CcSEcCtD
Tretinoin—Loss of consciousness—Doxorubicin—thyroid cancer	5.27e-05	0.000391	CcSEcCtD
Tretinoin—Infection—Epirubicin—thyroid cancer	5.25e-05	0.000389	CcSEcCtD
Tretinoin—Cough—Doxorubicin—thyroid cancer	5.23e-05	0.000388	CcSEcCtD
Tretinoin—Shock—Epirubicin—thyroid cancer	5.2e-05	0.000386	CcSEcCtD
Tretinoin—Convulsion—Doxorubicin—thyroid cancer	5.19e-05	0.000385	CcSEcCtD
Tretinoin—Nervous system disorder—Epirubicin—thyroid cancer	5.18e-05	0.000384	CcSEcCtD
Tretinoin—Thrombocytopenia—Epirubicin—thyroid cancer	5.18e-05	0.000384	CcSEcCtD
Tretinoin—Hypertension—Doxorubicin—thyroid cancer	5.17e-05	0.000384	CcSEcCtD
Tretinoin—Tachycardia—Epirubicin—thyroid cancer	5.16e-05	0.000383	CcSEcCtD
Tretinoin—Skin disorder—Epirubicin—thyroid cancer	5.13e-05	0.000381	CcSEcCtD
Tretinoin—Hyperhidrosis—Epirubicin—thyroid cancer	5.11e-05	0.000379	CcSEcCtD
Tretinoin—Myalgia—Doxorubicin—thyroid cancer	5.1e-05	0.000378	CcSEcCtD
Tretinoin—Arthralgia—Doxorubicin—thyroid cancer	5.1e-05	0.000378	CcSEcCtD
Tretinoin—Chest pain—Doxorubicin—thyroid cancer	5.1e-05	0.000378	CcSEcCtD
Tretinoin—Anxiety—Doxorubicin—thyroid cancer	5.08e-05	0.000377	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	5.07e-05	0.000376	CcSEcCtD
Tretinoin—Discomfort—Doxorubicin—thyroid cancer	5.04e-05	0.000374	CcSEcCtD
Tretinoin—Anorexia—Epirubicin—thyroid cancer	5.04e-05	0.000374	CcSEcCtD
Tretinoin—CYP2C18—Metabolism—NDUFA13—thyroid cancer	5e-05	0.000459	CbGpPWpGaD
Tretinoin—Dry mouth—Doxorubicin—thyroid cancer	4.99e-05	0.00037	CcSEcCtD
Tretinoin—RXRA—Generic Transcription Pathway—MEN1—thyroid cancer	4.96e-05	0.000455	CbGpPWpGaD
Tretinoin—Hypotension—Epirubicin—thyroid cancer	4.94e-05	0.000366	CcSEcCtD
Tretinoin—Confusional state—Doxorubicin—thyroid cancer	4.93e-05	0.000366	CcSEcCtD
Tretinoin—Anaphylactic shock—Doxorubicin—thyroid cancer	4.89e-05	0.000363	CcSEcCtD
Tretinoin—Oedema—Doxorubicin—thyroid cancer	4.89e-05	0.000363	CcSEcCtD
Tretinoin—ALDH1A1—Metabolism—SLC5A5—thyroid cancer	4.88e-05	0.000448	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—SLC5A5—thyroid cancer	4.88e-05	0.000448	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—SLC5A5—thyroid cancer	4.88e-05	0.000448	CbGpPWpGaD
Tretinoin—CYP2A6—Biological oxidations—RXRA—thyroid cancer	4.88e-05	0.000448	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—TPR—thyroid cancer	4.87e-05	0.000447	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—TPR—thyroid cancer	4.87e-05	0.000447	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—MEN1—thyroid cancer	4.87e-05	0.000447	CbGpPWpGaD
Tretinoin—Infection—Doxorubicin—thyroid cancer	4.86e-05	0.00036	CcSEcCtD
Tretinoin—CYP1A1—Arachidonic acid metabolism—PTGS2—thyroid cancer	4.85e-05	0.000445	CbGpPWpGaD
Tretinoin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	4.82e-05	0.000357	CcSEcCtD
Tretinoin—Shock—Doxorubicin—thyroid cancer	4.81e-05	0.000357	CcSEcCtD
Tretinoin—CYP2A6—NRF2 pathway—NRG1—thyroid cancer	4.81e-05	0.000441	CbGpPWpGaD
Tretinoin—Nervous system disorder—Doxorubicin—thyroid cancer	4.8e-05	0.000356	CcSEcCtD
Tretinoin—Thrombocytopenia—Doxorubicin—thyroid cancer	4.79e-05	0.000355	CcSEcCtD
Tretinoin—Insomnia—Epirubicin—thyroid cancer	4.78e-05	0.000355	CcSEcCtD
Tretinoin—RARB—Gene Expression—MEN1—thyroid cancer	4.78e-05	0.000439	CbGpPWpGaD
Tretinoin—Tachycardia—Doxorubicin—thyroid cancer	4.77e-05	0.000354	CcSEcCtD
Tretinoin—Skin disorder—Doxorubicin—thyroid cancer	4.75e-05	0.000352	CcSEcCtD
Tretinoin—Paraesthesia—Epirubicin—thyroid cancer	4.75e-05	0.000352	CcSEcCtD
Tretinoin—Hyperhidrosis—Doxorubicin—thyroid cancer	4.73e-05	0.000351	CcSEcCtD
Tretinoin—Dyspnoea—Epirubicin—thyroid cancer	4.71e-05	0.00035	CcSEcCtD
Tretinoin—CYP2C18—Metabolism—CHST14—thyroid cancer	4.7e-05	0.000431	CbGpPWpGaD
Tretinoin—Somnolence—Epirubicin—thyroid cancer	4.7e-05	0.000349	CcSEcCtD
Tretinoin—RARG—Generic Transcription Pathway—PPARG—thyroid cancer	4.68e-05	0.000429	CbGpPWpGaD
Tretinoin—Anorexia—Doxorubicin—thyroid cancer	4.66e-05	0.000346	CcSEcCtD
Tretinoin—Dyspepsia—Epirubicin—thyroid cancer	4.65e-05	0.000345	CcSEcCtD
Tretinoin—Decreased appetite—Epirubicin—thyroid cancer	4.6e-05	0.000341	CcSEcCtD
Tretinoin—RARA—Gene Expression—MEN1—thyroid cancer	4.58e-05	0.000421	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—MEN1—thyroid cancer	4.58e-05	0.000421	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.58e-05	0.00042	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.58e-05	0.00042	CbGpPWpGaD
Tretinoin—Hypotension—Doxorubicin—thyroid cancer	4.57e-05	0.000339	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Epirubicin—thyroid cancer	4.56e-05	0.000338	CcSEcCtD
Tretinoin—Fatigue—Epirubicin—thyroid cancer	4.56e-05	0.000338	CcSEcCtD
Tretinoin—RXRA—Metabolism—NDUFA13—thyroid cancer	4.54e-05	0.000416	CbGpPWpGaD
Tretinoin—Pain—Epirubicin—thyroid cancer	4.52e-05	0.000335	CcSEcCtD
Tretinoin—Constipation—Epirubicin—thyroid cancer	4.52e-05	0.000335	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	4.46e-05	0.00033	CcSEcCtD
Tretinoin—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	4.45e-05	0.000408	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	4.45e-05	0.000408	CbGpPWpGaD
Tretinoin—Insomnia—Doxorubicin—thyroid cancer	4.42e-05	0.000328	CcSEcCtD
Tretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	4.42e-05	0.000406	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—RXRA—thyroid cancer	4.42e-05	0.000406	CbGpPWpGaD
Tretinoin—Paraesthesia—Doxorubicin—thyroid cancer	4.39e-05	0.000326	CcSEcCtD
Tretinoin—Dyspnoea—Doxorubicin—thyroid cancer	4.36e-05	0.000323	CcSEcCtD
Tretinoin—Feeling abnormal—Epirubicin—thyroid cancer	4.36e-05	0.000323	CcSEcCtD
Tretinoin—Somnolence—Doxorubicin—thyroid cancer	4.35e-05	0.000322	CcSEcCtD
Tretinoin—CYP4A11—Metabolism—HPGD—thyroid cancer	4.34e-05	0.000398	CbGpPWpGaD
Tretinoin—Gastrointestinal pain—Epirubicin—thyroid cancer	4.32e-05	0.000321	CcSEcCtD
Tretinoin—Dyspepsia—Doxorubicin—thyroid cancer	4.31e-05	0.000319	CcSEcCtD
Tretinoin—RXRG—Generic Transcription Pathway—PPARG—thyroid cancer	4.28e-05	0.000392	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CHST14—thyroid cancer	4.27e-05	0.000392	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	4.26e-05	0.000391	CbGpPWpGaD
Tretinoin—Decreased appetite—Doxorubicin—thyroid cancer	4.25e-05	0.000315	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	4.22e-05	0.000313	CcSEcCtD
Tretinoin—RXRA—Transmembrane transport of small molecules—TPR—thyroid cancer	4.22e-05	0.000387	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—CP—thyroid cancer	4.22e-05	0.000387	CbGpPWpGaD
Tretinoin—Fatigue—Doxorubicin—thyroid cancer	4.22e-05	0.000313	CcSEcCtD
Tretinoin—Urticaria—Epirubicin—thyroid cancer	4.2e-05	0.000311	CcSEcCtD
Tretinoin—RARB—Generic Transcription Pathway—PPARG—thyroid cancer	4.19e-05	0.000385	CbGpPWpGaD
Tretinoin—Constipation—Doxorubicin—thyroid cancer	4.18e-05	0.00031	CcSEcCtD
Tretinoin—Pain—Doxorubicin—thyroid cancer	4.18e-05	0.00031	CcSEcCtD
Tretinoin—Abdominal pain—Epirubicin—thyroid cancer	4.18e-05	0.00031	CcSEcCtD
Tretinoin—Body temperature increased—Epirubicin—thyroid cancer	4.18e-05	0.00031	CcSEcCtD
Tretinoin—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	4.15e-05	0.000381	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	4.15e-05	0.000381	CbGpPWpGaD
Tretinoin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	4.13e-05	0.000379	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—RXRA—thyroid cancer	4.1e-05	0.000377	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—RXRA—thyroid cancer	4.1e-05	0.000377	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—RXRA—thyroid cancer	4.1e-05	0.000377	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	4.03e-05	0.00037	CbGpPWpGaD
Tretinoin—Feeling abnormal—Doxorubicin—thyroid cancer	4.03e-05	0.000299	CcSEcCtD
Tretinoin—RARA—Generic Transcription Pathway—PPARG—thyroid cancer	4.02e-05	0.000369	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—PPARG—thyroid cancer	4.02e-05	0.000369	CbGpPWpGaD
Tretinoin—Gastrointestinal pain—Doxorubicin—thyroid cancer	4e-05	0.000297	CcSEcCtD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.99e-05	0.000366	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.99e-05	0.000366	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	3.95e-05	0.000363	CbGpPWpGaD
Tretinoin—CYP2B6—Biological oxidations—RXRA—thyroid cancer	3.94e-05	0.000361	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—MINPP1—thyroid cancer	3.91e-05	0.000359	CbGpPWpGaD
Tretinoin—Hypersensitivity—Epirubicin—thyroid cancer	3.89e-05	0.000289	CcSEcCtD
Tretinoin—Urticaria—Doxorubicin—thyroid cancer	3.89e-05	0.000288	CcSEcCtD
Tretinoin—Body temperature increased—Doxorubicin—thyroid cancer	3.87e-05	0.000287	CcSEcCtD
Tretinoin—Abdominal pain—Doxorubicin—thyroid cancer	3.87e-05	0.000287	CcSEcCtD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	3.86e-05	0.000355	CbGpPWpGaD
Tretinoin—CYP3A5—Biological oxidations—RXRA—thyroid cancer	3.85e-05	0.000353	CbGpPWpGaD
Tretinoin—Asthenia—Epirubicin—thyroid cancer	3.79e-05	0.000281	CcSEcCtD
Tretinoin—CYP2C18—Metabolism—HPGD—thyroid cancer	3.79e-05	0.000348	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	3.79e-05	0.000348	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—THRB—thyroid cancer	3.76e-05	0.000345	CbGpPWpGaD
Tretinoin—Pruritus—Epirubicin—thyroid cancer	3.74e-05	0.000277	CcSEcCtD
Tretinoin—CYP1A1—Biological oxidations—RXRA—thyroid cancer	3.63e-05	0.000334	CbGpPWpGaD
Tretinoin—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	3.62e-05	0.000332	CbGpPWpGaD
Tretinoin—Diarrhoea—Epirubicin—thyroid cancer	3.62e-05	0.000268	CcSEcCtD
Tretinoin—Hypersensitivity—Doxorubicin—thyroid cancer	3.6e-05	0.000267	CcSEcCtD
Tretinoin—CYP2A6—Metabolism—MINPP1—thyroid cancer	3.58e-05	0.000329	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—RXRA—thyroid cancer	3.57e-05	0.000327	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	3.54e-05	0.000325	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.52e-05	0.000323	CbGpPWpGaD
Tretinoin—Asthenia—Doxorubicin—thyroid cancer	3.51e-05	0.00026	CcSEcCtD
Tretinoin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	3.5e-05	0.000322	CbGpPWpGaD
Tretinoin—Dizziness—Epirubicin—thyroid cancer	3.5e-05	0.000259	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	3.47e-05	0.000319	CbGpPWpGaD
Tretinoin—Pruritus—Doxorubicin—thyroid cancer	3.46e-05	0.000257	CcSEcCtD
Tretinoin—RXRA—Metabolism—HPGD—thyroid cancer	3.44e-05	0.000316	CbGpPWpGaD
Tretinoin—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	3.37e-05	0.000309	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—CDK1—thyroid cancer	3.37e-05	0.000309	CbGpPWpGaD
Tretinoin—Vomiting—Epirubicin—thyroid cancer	3.36e-05	0.000249	CcSEcCtD
Tretinoin—Diarrhoea—Doxorubicin—thyroid cancer	3.35e-05	0.000248	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	3.34e-05	0.000306	CbGpPWpGaD
Tretinoin—Rash—Epirubicin—thyroid cancer	3.33e-05	0.000247	CcSEcCtD
Tretinoin—CYP2C8—Biological oxidations—RXRA—thyroid cancer	3.33e-05	0.000306	CbGpPWpGaD
Tretinoin—Dermatitis—Epirubicin—thyroid cancer	3.33e-05	0.000247	CcSEcCtD
Tretinoin—CYP3A7—Metabolism—NDUFA13—thyroid cancer	3.32e-05	0.000305	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	3.32e-05	0.000304	CbGpPWpGaD
Tretinoin—Headache—Epirubicin—thyroid cancer	3.31e-05	0.000246	CcSEcCtD
Tretinoin—CYP1A1—PPARA activates gene expression—PPARG—thyroid cancer	3.28e-05	0.000301	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—RXRA—thyroid cancer	3.26e-05	0.000299	CbGpPWpGaD
Tretinoin—Dizziness—Doxorubicin—thyroid cancer	3.23e-05	0.00024	CcSEcCtD
Tretinoin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	3.21e-05	0.000295	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	3.2e-05	0.000294	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—RXRA—thyroid cancer	3.2e-05	0.000293	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.16e-05	0.00029	CbGpPWpGaD
Tretinoin—Nausea—Epirubicin—thyroid cancer	3.14e-05	0.000233	CcSEcCtD
Tretinoin—CYP3A7—Metabolism—CHST14—thyroid cancer	3.13e-05	0.000287	CbGpPWpGaD
Tretinoin—Vomiting—Doxorubicin—thyroid cancer	3.11e-05	0.000231	CcSEcCtD
Tretinoin—Rash—Doxorubicin—thyroid cancer	3.08e-05	0.000229	CcSEcCtD
Tretinoin—Dermatitis—Doxorubicin—thyroid cancer	3.08e-05	0.000228	CcSEcCtD
Tretinoin—RARA—Gene Expression—RXRA—thyroid cancer	3.07e-05	0.000281	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—RXRA—thyroid cancer	3.07e-05	0.000281	CbGpPWpGaD
Tretinoin—Headache—Doxorubicin—thyroid cancer	3.06e-05	0.000227	CcSEcCtD
Tretinoin—CYP2A6—Metabolism—NDUFA13—thyroid cancer	3.05e-05	0.00028	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	3e-05	0.000275	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	2.95e-05	0.000271	CbGpPWpGaD
Tretinoin—Nausea—Doxorubicin—thyroid cancer	2.91e-05	0.000215	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.89e-05	0.000266	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—MINPP1—thyroid cancer	2.89e-05	0.000265	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	2.88e-05	0.000265	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CHST14—thyroid cancer	2.87e-05	0.000263	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—MINPP1—thyroid cancer	2.83e-05	0.000259	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—PPARG—thyroid cancer	2.79e-05	0.000256	CbGpPWpGaD
Tretinoin—CYP2C9—Biological oxidations—RXRA—thyroid cancer	2.71e-05	0.000249	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—MINPP1—thyroid cancer	2.67e-05	0.000245	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PPARG—thyroid cancer	2.59e-05	0.000238	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PPARG—thyroid cancer	2.59e-05	0.000238	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PPARG—thyroid cancer	2.59e-05	0.000238	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—TPR—thyroid cancer	2.54e-05	0.000233	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—HPGD—thyroid cancer	2.52e-05	0.000231	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—TPR—thyroid cancer	2.49e-05	0.000229	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—NDUFA13—thyroid cancer	2.46e-05	0.000226	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PRKAR1A—thyroid cancer	2.45e-05	0.000225	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—MINPP1—thyroid cancer	2.45e-05	0.000225	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—NDUFA13—thyroid cancer	2.4e-05	0.000221	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MEN1—thyroid cancer	2.39e-05	0.000219	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CHST14—thyroid cancer	2.31e-05	0.000212	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—HPGD—thyroid cancer	2.31e-05	0.000212	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—NDUFA13—thyroid cancer	2.27e-05	0.000208	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CHST14—thyroid cancer	2.26e-05	0.000207	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—PPARG—thyroid cancer	2.25e-05	0.000207	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.22e-05	0.000204	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.22e-05	0.000204	CbGpPWpGaD
Tretinoin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	2.21e-05	0.000203	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—TPR—thyroid cancer	2.18e-05	0.0002	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PRKAR1A—thyroid cancer	2.14e-05	0.000197	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CHST14—thyroid cancer	2.13e-05	0.000196	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—PPARG—thyroid cancer	2.1e-05	0.000192	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—NDUFA13—thyroid cancer	2.08e-05	0.000191	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—PPARG—thyroid cancer	2.06e-05	0.000189	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PTGS2—thyroid cancer	2.04e-05	0.000187	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PTGS2—thyroid cancer	2.04e-05	0.000187	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PTGS2—thyroid cancer	2.04e-05	0.000187	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—PPARG—thyroid cancer	2.02e-05	0.000185	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—MINPP1—thyroid cancer	1.99e-05	0.000183	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—TPR—thyroid cancer	1.98e-05	0.000181	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.97e-05	0.000181	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—PPARG—thyroid cancer	1.97e-05	0.000181	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CHST14—thyroid cancer	1.96e-05	0.00018	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PRKAR1A—thyroid cancer	1.94e-05	0.000178	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—PPARG—thyroid cancer	1.94e-05	0.000178	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—PPARG—thyroid cancer	1.94e-05	0.000178	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—SLC5A5—thyroid cancer	1.86e-05	0.000171	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—HPGD—thyroid cancer	1.86e-05	0.000171	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—HPGD—thyroid cancer	1.82e-05	0.000167	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—RXRA—thyroid cancer	1.79e-05	0.000164	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PTEN—thyroid cancer	1.78e-05	0.000163	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PTEN—thyroid cancer	1.78e-05	0.000163	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PTEN—thyroid cancer	1.78e-05	0.000163	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.76e-05	0.000162	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.75e-05	0.00016	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—HPGD—thyroid cancer	1.72e-05	0.000158	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NDUFA13—thyroid cancer	1.69e-05	0.000155	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.67e-05	0.000153	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—SLC5A5—thyroid cancer	1.63e-05	0.00015	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CHST14—thyroid cancer	1.59e-05	0.000146	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—HPGD—thyroid cancer	1.58e-05	0.000145	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—RXRA—thyroid cancer	1.57e-05	0.000144	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.52e-05	0.00014	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—SLC5A5—thyroid cancer	1.48e-05	0.000136	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—TPR—thyroid cancer	1.45e-05	0.000133	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	1.42e-05	0.000131	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.4e-05	0.000128	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.39e-05	0.000127	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—RXRA—thyroid cancer	1.37e-05	0.000126	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—TPR—thyroid cancer	1.33e-05	0.000122	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—MINPP1—thyroid cancer	1.31e-05	0.000121	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	1.3e-05	0.00012	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—HPGD—thyroid cancer	1.28e-05	0.000118	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.28e-05	0.000117	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.21e-05	0.000111	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—NRAS—thyroid cancer	1.21e-05	0.000111	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NDUFA13—thyroid cancer	1.12e-05	0.000103	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—AKT1—thyroid cancer	1.1e-05	0.000101	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—SLC5A5—thyroid cancer	1.08e-05	9.94e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—TPR—thyroid cancer	1.07e-05	9.82e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	1.05e-05	9.66e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CHST14—thyroid cancer	1.05e-05	9.64e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—TPR—thyroid cancer	1.05e-05	9.6e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.04e-05	9.56e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—KRAS—thyroid cancer	1.04e-05	9.53e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	1.03e-05	9.44e-05	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—AKT1—thyroid cancer	1.02e-05	9.4e-05	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—AKT1—thyroid cancer	1.02e-05	9.4e-05	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—AKT1—thyroid cancer	1.02e-05	9.4e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—PPARG—thyroid cancer	1.01e-05	9.26e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—SLC5A5—thyroid cancer	9.93e-06	9.11e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PPARG—thyroid cancer	9.89e-06	9.08e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—TPR—thyroid cancer	9.88e-06	9.07e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	9.72e-06	8.92e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—RXRA—thyroid cancer	9.1e-06	8.35e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—TPR—thyroid cancer	9.06e-06	8.31e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	8.91e-06	8.18e-05	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—AKT1—thyroid cancer	8.9e-06	8.17e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—HRAS—thyroid cancer	8.83e-06	8.1e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	8.81e-06	8.09e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PPARG—thyroid cancer	8.64e-06	7.93e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HPGD—thyroid cancer	8.47e-06	7.77e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—RXRA—thyroid cancer	8.34e-06	7.66e-05	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—AKT1—thyroid cancer	8.14e-06	7.47e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	8.08e-06	7.41e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—SLC5A5—thyroid cancer	8.01e-06	7.35e-05	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—AKT1—thyroid cancer	7.98e-06	7.33e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PPARG—thyroid cancer	7.84e-06	7.2e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—SLC5A5—thyroid cancer	7.83e-06	7.19e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—AKT1—thyroid cancer	7.8e-06	7.16e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTGS2—thyroid cancer	7.78e-06	7.14e-05	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—AKT1—thyroid cancer	7.65e-06	7.02e-05	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—AKT1—thyroid cancer	7.65e-06	7.02e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SLC5A5—thyroid cancer	7.4e-06	6.79e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—TPR—thyroid cancer	7.37e-06	6.77e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	7.25e-06	6.66e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.93e-06	6.36e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTGS2—thyroid cancer	6.8e-06	6.24e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTEN—thyroid cancer	6.78e-06	6.23e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SLC5A5—thyroid cancer	6.78e-06	6.22e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—RXRA—thyroid cancer	6.73e-06	6.18e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—RXRA—thyroid cancer	6.58e-06	6.04e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.58e-06	6.03e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.36e-06	5.83e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—RXRA—thyroid cancer	6.22e-06	5.7e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTGS2—thyroid cancer	6.17e-06	5.66e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.05e-06	5.55e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTEN—thyroid cancer	5.93e-06	5.44e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PPARG—thyroid cancer	5.75e-06	5.27e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—RXRA—thyroid cancer	5.7e-06	5.23e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.54e-06	5.09e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC5A5—thyroid cancer	5.52e-06	5.07e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTEN—thyroid cancer	5.38e-06	4.94e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PPARG—thyroid cancer	5.27e-06	4.83e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.17e-06	4.75e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—TPR—thyroid cancer	4.86e-06	4.46e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	4.78e-06	4.39e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—RXRA—thyroid cancer	4.64e-06	4.26e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGS2—thyroid cancer	4.52e-06	4.15e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.51e-06	4.14e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PPARG—thyroid cancer	4.25e-06	3.9e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PPARG—thyroid cancer	4.15e-06	3.81e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGS2—thyroid cancer	4.14e-06	3.8e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—AKT1—thyroid cancer	3.99e-06	3.66e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTEN—thyroid cancer	3.94e-06	3.62e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PPARG—thyroid cancer	3.92e-06	3.6e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—AKT1—thyroid cancer	3.91e-06	3.59e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC5A5—thyroid cancer	3.64e-06	3.34e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTEN—thyroid cancer	3.61e-06	3.32e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PPARG—thyroid cancer	3.6e-06	3.3e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—AKT1—thyroid cancer	3.42e-06	3.14e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGS2—thyroid cancer	3.34e-06	3.07e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGS2—thyroid cancer	3.27e-06	3e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—AKT1—thyroid cancer	3.1e-06	2.85e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGS2—thyroid cancer	3.09e-06	2.83e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—RXRA—thyroid cancer	3.06e-06	2.81e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PPARG—thyroid cancer	2.93e-06	2.69e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTEN—thyroid cancer	2.92e-06	2.68e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTEN—thyroid cancer	2.85e-06	2.62e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGS2—thyroid cancer	2.83e-06	2.6e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTEN—thyroid cancer	2.69e-06	2.47e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTEN—thyroid cancer	2.47e-06	2.27e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS2—thyroid cancer	2.3e-06	2.11e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—AKT1—thyroid cancer	2.27e-06	2.09e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—AKT1—thyroid cancer	2.08e-06	1.91e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTEN—thyroid cancer	2.01e-06	1.84e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPARG—thyroid cancer	1.93e-06	1.77e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—AKT1—thyroid cancer	1.68e-06	1.54e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—AKT1—thyroid cancer	1.64e-06	1.51e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—AKT1—thyroid cancer	1.55e-06	1.42e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.52e-06	1.39e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AKT1—thyroid cancer	1.42e-06	1.31e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTEN—thyroid cancer	1.32e-06	1.22e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AKT1—thyroid cancer	1.16e-06	1.06e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AKT1—thyroid cancer	7.64e-07	7.01e-06	CbGpPWpGaD
